Universal-Beteiligungs- und Servicegesellschaft
PVLA icon

Universal-Beteiligungs- und Servicegesellschaft’s Palvella Therapeutics PVLA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
4,307
+763
+22% +$92.6K ﹤0.01% 1713
2026
Q1 		$442K Buy
+3,544
New +$370K ﹤0.01% 1760

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's PVLA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Palvella Therapeutics (PVLA) stake by 22% in Q2 2026, buying an estimated $92.6K and bringing the position to 4,307 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PVLA in Q1 2026 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 4,307 shares of Palvella Therapeutics worth $658K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 763 Palvella Therapeutics shares in Q2 2026, an estimated $92.6K.
  • Palvella Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1713 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.